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Abstract
Background:  Lung function is a strong predictor of cardiovascular and all-cause mortality.
Previous studies suggest that alcohol exposure may be linked to impaired pulmonary function
through oxidant-antioxidant mechanisms. Alcohol may be an important source of oxidants;
however, wine contains several antioxidants. In this study we analyzed the relation of beverage
specific alcohol intake with forced expiratory volume in one second (FEV1) and forced vital capacity
(FVC) in a random sample of 1555 residents of Western New York, USA.
Methods: We expressed pulmonary function as percent of predicted normal FEV1 (FEV1%) and
FVC (FVC%) after adjustment for height, age, gender and race. To obtain information on alcohol
intake we used a questionnaire that reliably queries total alcohol and beverage specific recent (past
30 days) and lifetime alcohol consumption. Results: Using multiple linear regression analysis after
adjustment for covariates (pack-years of smoking, weight, smoking status, education, nutritional
factors and for FEV1%, in addition, eosinophil count), we observed no significant correlation
between total alcohol intake and lung function. However, we found positive associations of recent
and lifetime wine intake with FEV1% and FVC%. When we analyzed white and red wine intake
separately, the association of lung function with red wine was weaker than for white wine.
Conclusion: While total alcohol intake was not related to lung function, wine intake showed a
positive association with lung function. Although we cannot exclude residual confounding by
healthier lifestyle in wine drinkers, differential effects of alcoholic beverages on lung health may
exist.
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Background
Impaired pulmonary function is a strong predictor of car-
diovascular and all-cause mortality in the general popula-
tion independent of smoking [1–4]. The factors that
influence pulmonary function are not completely under-
stood and oxidant exposure could play a negative role [5–
7]. Support for this hypothesis comes from studies that re-
port a positive association between antioxidant vitamin
status and lung function [8–11]. Several studies have indi-
cated that alcohol exposure may contribute to oxidative
burden and, therefore, it may be linked to impaired pul-
monary function through oxidant-antioxidant mecha-
nisms [12–15]. However, while alcohol itself can act as an
oxidant, wine has antioxidant properties [12,13,16,17].
An early report by Cohen et al. [18] did not show an effect
of total alcohol intake on lung function, but a number of
cross-sectional studies subsequently have shown high al-
cohol intake to be negatively associated with lung func-
tion and positively related to the occurrence of respiratory
symptoms [19–24]. However, several recent studies failed
to show a negative association of alcohol intake with lung
function or respiratory symptoms [25–27]. Thus, the evi-
dence is contradictory and oxidants or antioxidants asso-
ciated with different alcoholic beverages may be
responsible for these conflicting results [12–14,28]. Only
one study has investigated the association between bever-
age specific alcohol intake and pulmonary function. In
that study, Cohen et al. [18] did not find beverage-specific
effects on pulmonary function. However, there is evidence
that alcoholic beverages could differ in their effects on
lung health due to differences in their constituents from a
study linking beverage specific alcohol intake to lung can-
cer risk [29]. In addition, no study has investigated life-
time alcohol intake and white and red wine intake
separately in relation to pulmonary function. Therefore,
the goal of this study was to describe the relation of bev-
erage specific alcohol intake with pulmonary function
(FEV1 and FVC) in a general population sample. In order
to investigate whether effects of recent alcohol intake dif-
fer from long term effects we considered both recent as
well as lifetime beverage specific alcohol intake in this
analysis.
Materials and Methods
We report here on data from a general-population sample
drawn from Erie and Niagara Counties in New York State,
USA, between September 1995 and December 1998. A de-
tailed description of the study design, participant recruit-
ment and methodology has been reported previously
[11]. The ethics review board of the University at Buffalo,
New York, USA, approved the study.
Study population
In brief, we utilized New York State Department of Motor
Vehicles and Health Care Finance Association lists to ran-
domly select participants aged 35–79 years. Of the 4946
initially contacted eligible subjects 2537 (1,322 female
and 1,215 male) participated (51.3 percent). The follow-
ing exclusion criteria applied to the current analysis: race
other than Caucasian or African-American (n = 33), miss-
ing information on diet (n = 111), missing information
on height, weight, smoking status, laboratory values or
education (n = 177), missing pulmonary function tests (n
= 250), unacceptable or not reproducible pulmonary
function tests (n = 108), a history of COPD, asthma or
pulmonary fibrosis (n = 249) or missing information on
alcohol intake (n = 54). The remaining 1555 participants
(814 women and 741 men) are included in this report.
The excluded participants for whom information was
available were comparable to the included participants in
regards to gender and race. We did not find a statistically
significant difference between included and excluded par-
ticipants for age, height and weight, but as a result of the
higher prevalence of asthma and COPD excluded partici-
pants had lower values of FEV1 and FVC.
Interview and Examination
The examination included an in-person interview about
life-style habits, a self-administered questionnaire, an-
thropometric measurements and spirometry. Between
6:30 and 9:30 am we obtained spirometric measurements
from participants, standardized according to 1994 Ameri-
can Thoracic Society guidelines [30]. To derive forced ex-
piratory volume in one second (FEV1) and forced vital
capacity (FVC) prediction equations we used multiple lin-
ear regression with values obtained from lifelong non-
smokers who did not report a history of chronic lung
disease for men (n = 277) and women (n = 418) separate-
ly. We chose the model that explained the greatest fraction
of variability (R2) in lung function.
We obtained the following equations for men,
predicted FEV1 = -0.550 - 0.0359 ×  age (years) + 3.603 ×
height (m) -0.478 ×  race
predicted FVC = -2.229 - 0.0382 ×  age (years) + 5.210 ×
height (m) -0.739 ×  race
and for women,
predicted FEV1 = -0.184 - 0.0298 ×  age (years) + 2.829 ×
height (m) - 0.309 ×  race
predicted FVC = -1.413 - 0.0318 ×  age (years)+ 4.104 ×
height (m) - 0.514 ×  raceBMC Pulmonary Medicine 2002, 2 http://www.biomedcentral.com/1471-2466/2/3
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with race as a dummy variable (Caucasian = 0, African-
American = 1). We then calculated FEV1 and FVC in per-
cent of the predicted value (FEV1% and FVC%) adjusted
for age, gender, height and race for all participants [11].
Alcohol intake
We obtained information about alcohol intake with a
computer assisted in-person interview [31]. Interviewers
underwent extensive training and standardization. Alco-
hol consumption was assessed for the past 30 days and
during participants' lifetimes [32,33]. We defined partici-
pants who reported consumption of less than 12 drinks
during their lifetime as lifetime abstainers (never drink-
ers) and those who reported 12 or more drinks during
their lifetime but never consumed alcoholic beverages in
the past 30 days as former drinkers (non-current drink-
ers).
We asked participants who drank during the past 30 days
which of four major types of alcoholic beverages beer,
wine, wine cooler, and hard liquor they had drunk at least
once. Participants defined their usual drink size in ounces
for each beverage they drank using bottles of various sizes
and sample glasses with drink sizes marked on the side to
improve the accuracy of their estimates. Participants were
then asked how often they drank during the last 30 days,
and those who drank less often than once a week were
asked how many drinks they usually had on a day when
they drank alcohol. Respondents who drank once a week
or more often were asked about their pattern of drinking
– how many Fridays in the past 30 days did they drink,
how many drinks did they usually have on a Friday when
they drank, and what beverage(s) did they drink? These
questions were repeated for Saturdays, Sundays, and
weekdays. We also asked quantity-frequency questions for
times participants drank more than usual. This data was
used to estimate the number of drinks consumed of each
beverage over the past 30 days, which was then multiplied
by drink size to get beverage-specific ounces of alcohol
consumed. We then calculated beverage-specific grams of
alcohol using the following conversion factors: 0.045,
0.121, 0.04, and 0.409 grams of alcohol per ounce, for
beer, wine, wine cooler and hard liquor, respectively
We used the Cognitive Lifetime Drinking History (CLDH)
to obtain information on lifetime alcohol intake [31–33].
Prior to the interview, participants completed a lifetime
events calendar on which they recorded the date and their
age when significant events in their lives occurred. This
calendar was used during the interview to help them re-
member what they were doing during different periods of
their lives and whether drinking alcohol was involved.
Participants reported how old they were when they started
drinking alcohol regularly – at least once a month for six
months and when their drinking patterns changed. This
information was used to define intervals during their lives
when drinking patterns were fairly homogeneous. For
each interval, participants were asked questions on drink-
ing pattern comparable to those asked for the past 30 days
and asked to estimate what percentage of the drinks con-
sumed during that interval came from the specific bever-
ages consumed during that interval. This information was
used to estimate beverage-specific grams of alcohol con-
sumed in the interval, and these estimates were summed
across intervals to arrive at lifetime totals. Total alcohol in-
take was expressed in kg during participants' lifetimes.
We have previously demonstrated construct validity of the
questionnaires. In a study involving 147 subjects [32], we
compared the average daily volume of alcohol consumed
during the 12–24 months prior to the interview as esti-
mated from the alcohol questionnaire with those estimat-
ed from two different food frequency questionnaires
(FFQ), the Health Habits and History Questionnaire and
the Harvard Semiquantitative Food Frequency Question-
naire. FFQs have been shown to produce valid estimates
of alcohol intake, with correlations of about 0.5–0.9. In
this study, the CLDH compared favorably to the FFQs
with correlations between 0.7 and 0.8, and therefore we
can infer reasonable validity. Because the FFQs query in-
take over a one year period, we did not estimate 30 day in-
take in that study. Furthermore, the repeatability of the
CLDH over an average two week period was excellent (r =
0.84) indicating that this questionnaire performs well in
measurement of short term alcohol intake.
Statistical methods and analysis
We examined the distributions of the continuous varia-
bles for all relevant variables to determine if they were
normally distributed and calculated mean values and
standard deviation (SD). We also performed descriptive
analyses separating drinkers by beverage types consumed
and compared drinkers of specific beverages but there
were only few participants who consumed one type of al-
coholic beverage exclusively. For the analyses related to al-
cohol intake we used recent intake (last 30 days) and
lifetime alcohol intake with ounces converted into metric
units. To investigate the association between the alcohol
intake variables we calculated Pearson's correlation coeffi-
cients. For both total and white and red wine separately
we observed weak correlations (r < 0.2) with beer and liq-
uor intake for recent and lifetime total intake. The correla-
tion between red and white wine intake were high for
both recent (r = 0.8) and lifetime (r = 0.5) intake. Howev-
er, the correlations between recent and lifetime alcohol
intake were only weak to moderate ranging from r = 0.13
for liquor, r = 0.17 for total alcohol, r = 0.29 for wine to r
= 0.37 for beer intake. These correlation coefficients did
not differ significantly between men and women.BMC Pulmonary Medicine 2002, 2 http://www.biomedcentral.com/1471-2466/2/3
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The principal analysis we used was multiple linear regres-
sion analysis including all 1555 subjects. The total and
beverage specific alcohol intake variables were not nor-
mally distributed and, therefore, we performed a logarith-
mic transformation. Transformation was based on Ig10
(alcohol intake +1), where alcohol intake resembles cur-
rent or lifetime beverage specific or total alcohol intake,
respectively. The dependent variables were FEV1% and
FVC% and the independent variables were the specific al-
coholic beverage. Previously, we found that weight, eosi-
nophil count, education, smoking status and cumulative
tobacco smoke exposure in pack-years of smoking predict
FEV1% with the largest variance explained and therefore,
we included these variables in the baseline model [11].
Because eosinophil count was not significantly correlated
with FVC% only total pack years of smoking, smoking sta-
tus, education and weight were included in the baseline
model predicting FVC%. In addition, we previously re-
ported that several serum and dietary antioxidant vita-
mins were correlated with pulmonary function [11,34].
Therefore, we included serum antioxidant vitamins in the
regression models for FEV1% (vitamin E, vitamin C,
lutein/zeaxanthin,  β -cryptoxanthin and retinol) and
FVC% (vitamin E, vitamin C, β -cryptoxanthin and lutein/
zeaxanthin).
To define statistical significance we used the conventional
level of p < 0.05. However, we determined that interaction
terms would be important if the level of significance was
p < 0.1. We investigated interaction by including interac-
tion terms of beverage specific alcohol intake, smoking
status (never, former, current), gender and other covari-
ates and stratification, but we did not observe statistically
significant interactions. We also examined the regression
models for multicollinearity. Significant collinearity was
present only for the analyses that included both white and
red wine intake. For the analyses we utilized the Statistical
Package for Social Sciences and SPLUS.
Results
Demographic characteristics, spirometry and alcohol in-
take
Table 1 shows the characteristics of the study participants
included in this analysis. Mean age was 59.6 years and,
based on mean body mass index, participants tended to
be overweight. The study population included slightly
more women than men, approximately 43.6 percent were
former smokers and 13.6 percent were current smokers.
There were few never drinkers of alcohol and the majority
of participants consumed several alcoholic beverages
presently. For both recent daily alcohol intake and life-
time alcohol consumption we observed the highest intake
for beer, followed by liquor and wine. On average, partic-
ipants had consumed larger quantities of white wine than
red wine. Mean alcohol intake from wine coolers was low
and therefore we did not further investigate this beverage.
Demographic characteristics and spirometry by recent 
beverage specific alcohol intake
Table 2 shows the characteristics of participants by recent
beverage specific alcohol intake. Beer only drinkers were
younger than other participants, but those in the liquor
only group had a higher BMI than those in the other
groups. The beer only group included predominantly men
while the groups of wine only, liquor only and recent ab-
stainers included more women than men. The education
level was highest in the groups with only wine intake and
with mixed drinking pattern. Cumulative tobacco smoke
exposure was highest in the beer drinker group and lowest
among wine drinkers. Recent average alcohol intake was
highest among those with a mixed drinking pattern and
Table 1: Characteristics of participants
Variable (unit) Value (SD†)
Age (years) 59.9 (10.7)
BMI (kg/m2)‡ 28.2 (5.2)
FVC (liter) 3.82 (1.01)
FEV1 (liter) 2.90 (0.80)
FVC%‡ (%) 98.4 (15.2)
FEV1%‡ (%) 96.5 (16.4)
Women (%) 52.3%
African-American (%) 6.9%
Smoking
Never-Smoker (%) 42.8%
Ex-Smoker (%) 43.5%
Current-Smoker (%) 13.7%
Pack-years of smoking 14.8 (23.0)
Alcohol Intake
Never Drinkers 3.0%
Current Drinkers 68.1%
Non-Current Drinkers 28.8%
Past 30 days alcohol intake
Total Alcohol (g/day)§ 8.2 (17.8)
Beer (g/day)§ 3.0 (8.8)
White Wine (g/day)§ 1.3 (5.0)
Red Wine (g/day)§ 1.0 (3.4)
Fortified Wine (g/day)§ 0.03 (0.5)
Liquor (g/day)§ 2.8 (13.6)
Lifetime alcohol intake
Total Alcohol (kg) 210.6 (600.6)
Beer(kg) 98.7 (215.3)
White Wine (kg) 16.6 (127.1)
Red Wine (kg) 10.4 (37.6)
Fortified Wine (kg) 2.7 (35.5)
Liquor (kg) 81.6 (495.0)
†SD, standard deviation, for categorical variables prevalence is given 
‡BMI, body mass index; FEV1, forced vital capacity in one second in 
percent of predicted; FVC%, forced vital capacity in percent of pre-
dicted § in the 30 days prior to the interviewBMC Pulmonary Medicine 2002, 2 http://www.biomedcentral.com/1471-2466/2/3
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lowest in the wine only group. Nutritional status indica-
tors showed that wine drinkers had the highest levels of
serum antioxidant vitamins. Both mean FEV1% and
FVC% (corrected for age, weight and gender) were highest
among participants who consumed various alcoholic bev-
erages or wine only.
Regression analysis of recent alcohol intake on FEV1% and 
FVC%
Table 3 summarizes the results of multiple linear regres-
sion analysis for recent total alcohol and beverage specific
alcohol intake after inclusion of all covariates in the base-
line model. Multiple linear regression of FEV1% revealed
independent associations with alcohol intake from wine
for both FEV1% and FVC% when variables were entered
separately. The association attained statistical significance
only for white wine when we entered red and white wine
intake variables simultaneously. Even after inclusion of
other beverage specific alcohol variables, alcohol intake
from wine was at least borderline significantly related to
FEV1% and FVC%. Alcohol intake from beer and liquor
showed little or no association with lung function.
Regression analysis of lifetime alcohol intake on FEV1% 
and FVC%
Next we explored the association between lifetime bever-
age specific alcohol intake and lung function. Table 4
shows the results of multiple linear regression analysis for
lifetime total and beverage specific alcohol intake after ad-
justment for other covariates. Cumulative alcohol intake
from both red wine and white wine was significantly and
positively related to both FEV1% and FVC% when these
variables were considered separately. Similar to the results
for recent alcohol intake the association was stronger for
white wine compared with red wine. Total alcohol intake
and alcohol intake from beer and liquor were not correlat-
ed with pulmonary function. Alcohol intake from wine
was significantly associated with lung function even after
inclusion of alcohol intake from beer and liquor. The as-
sociation of alcohol intake from white wine persisted even
after inclusion of other alcohol variables in the regression
model, but red wine was not significantly related to lung
function (data not shown). There was no statistically sig-
nificant association between lifetime wine intake and
lung function after we included recent alcohol intake
from wine in the regression models.
Other models examined
We did not observe a statistically significant interaction
between smoking status and alcohol intake. Because of
the possibility that alcohol intake was particularly harm-
ful in those with heavy alcohol consumption (a subgroup
of the population that consumed predominantly large
quantities of beer and liquor) and because an association
between light drinking and lung function could be influ-
enced by heavy drinking, we investigated whether the cor-
relation between lifetime beverage specific alcohol intake
and lung function were similar in the group with lower al-
cohol intake. For this analysis we included participants
below the median of total alcohol intake. In this subgroup
Table 2: Characteristics of participants by drinker type (recent alcohol intake)
Wine only               
N = 231
Beer only               
N = 197
Liquor only           
N = 149
Various beverages 
types N = 484
Recent abstainers 
N = 494
Variable (unit) Value (SD†)V a l u e  ( S D †)V a l u e  ( S D †)V a l u e  ( S D †)V a l u e  ( S D †)
Age (years) 60.6 10.2 57.4 11.1 61.4 10.6 59.0 10.6 60.9 10.6
BMI (kg/m2)‡ 26.8 4.9 27.9 4.6 29.2 5.5 27.8 4.8 28.9 5.8
Women (%) 68.8% 26.9% 53.7% 43.8% 62.8%
College Education (%)* 70.1% 49.2% 52.3% 66.7% 41.7%
Pack-years of smoking 10.3 20.1 19.3 29.2 17.1 23.0 14.7 20.4 14.6 23.7
Recent alcohol intake 
(gr/day)
6.8 11.7 11.9 18.3 12.6 28.4 14.3 21.3 - -
Serum (β -cryptoxan-
thin (µg/ml)
.116 .084 .088 .064 .094 .076 .097 .065 .095 .065
Serum Vitamin E (ng 
per mg/dl triglycerides)
.144 .096 .108 .058 .110 .071 .128 .074 .119 .065
FVC%‡ (%) 99.7 14.7 98.0 15.6 94.8 15.0 100.3 14.7 97.0 15.7
FEV1%‡ (%) 97.2 15.9 94.7 16.8 93.4 16.7 98.8 15.1 95.5 17.2
†SD, standard deviation, for categorical variables prevalence is given ‡BMI, body mass index; FEV1, forced vital capacity in one second in percent of 
predicted; FVC%, forced vital capacity in percent of predicted § in the 30 days prior to the interview * at least some college educationBMC Pulmonary Medicine 2002, 2 http://www.biomedcentral.com/1471-2466/2/3
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of the study population mean lifetime intake was 20.4 kg
for total alcohol, 4.4 kg for alcohol from white wine, 2.6
kg for red wine, 6.0 kg for beer and 6.9 kg for liquor. Using
multiple linear regression analysis with adjustment for the
known covariates alcohol intake from white wine re-
mained the strongest correlate of FEV1% and FVC (data
Table 3: Multiple linear regression coefficients for regression of recent (prior month) total alcohol and beverage specific alcohol intake 
on FEV1% and FVC%
Variable FEBV1%† FVC%‡
β 95% CI β 95% CI
Recent alcohol intake# Variables entered separately
Total alcohol 0.689 -0.737–2.116 0.802 -0.554–2.157
Total Wine (red and white wine) 2.027* 0.011–4.044 2.240* 0.307–4.173
White Wine 3.058* 0.603–5.514 2.900* 0.543–5.257
Red Wine 1.211 -1.500–3.922 1.440 -1.160–4.040
Beer 0.394 -1.396–2.184 0.564 -1.144–2.267
Liquor 0.561 -1.411–2.532 0.129 -1.753–2.010
Recent alcohol intake# Variables entered simultaneously
Total Wine (red and white wine) 1.979p = 0.056 -.0.047–4.006 2.219* 0.276–4.163
Beer 0.269 -1.527–2.067 0.456 -1.258–2.171
Liquor 0.374 -1.610–2.358 -0.110 -2.006–1.785
† adjusted for smoking status (never, former, current), total pack-years of smoking, weight, education, eosinophil count and serum vitamin E, vita-
min c, lutein/zeaxanthin, β -cryptoxanthin and retinol levels ‡ adjusted for smoking status, total pack-years of smoking, weight, education and serum 
vitamin E, vitamin C, β -cryptoxanthin and lutein/zeaxanthin levels # alcohol variables, expressed in gram/day, were log transformed to closer 
approximate a normal distribution. Transformation is based on Ig10 (alcohol intake + 1), where alcohol intake resembles beverage specific or total 
intake over past 30 days *p < 0.05, **p < 0.01
Table 4: Multiple linear regression coefficients for regression of lifetime total alcohol and beverage specific alcohol intake on FEV1% and 
FVC%,
Variable FEBV1%† FVC%‡
β 95% CI β 95% CI
Lifetime alcohol intake# Variables entered separately
Total alcohol 0.001 -0.999–1.017 0.271 -0.687–1.228
Total Wine (red and white wine) 1.607** 0.593–2.621 1.267* 0.292–2.241
White Wine 1.825** 0.660–2.990 1.396* 0.277–2.516
Red Wine 1.277* 0.008–2.546 1.262* 0.044–2.480
Beer -0.387 -1.193–0.419 -0.056 -0.823–0.711
Liquor -0.042 -0.825–0.909 -0.135 -0.966–0.697
Lifetime alcohol intake# Variables entered simultaneously
Total Wine (red and white wine) 1.696** 0.662–2.730 1.349** 0.355–2.343
Beer -0.503 -1.007–0.791 -0.097 -0.884–0.691
Liquor -0.108 -1.007–0.791 -0.324 -1.187–0.540
†adjusted for smoking status (never, former, current), total pack-years of smoking, weight, education, eosinophil count and serum vitamin E, vitamin 
c, lutein/zeaxanthin, β -cryptoxanthin and retinol levels ‡ adjusted for smoking status, total pack-years of smoking, weight, education and serum vita-
min E, vitamin C, β -cryptoxanthin and lutein/zeaxanthin levels # alcohol variables, expressed in kg, were log transformed to closer approximate a 
normal distribution. Transformation is based on Ig10 (alcohol intake + 1), where alcohol intake resembles beverage specific or total intake over the 
lifetime *p < 0.05, **p < 0.01BMC Pulmonary Medicine 2002, 2 http://www.biomedcentral.com/1471-2466/2/3
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not shown). The regression coefficients (95% confidence
intervals, CI) on FEV1% for wine intake were 2.024 (0.075
– 3.973) in those below the median and 1.967 (0.628 –
3.306) for those above the median.
When we performed regression analysis separately by type
of recent alcohol intake, there was a trend that among
those drinking various beverages recently wine intake was
positively associated with lung function. The regression
coefficient on FEV1% for wine intake was 1.743 (95% CI,
-1.197 – 4.682). For comparison, it was 2.362 (95% CI, -
2.490 – 7.214) in those who drank only wine. 25% of
those drinking various beverages did not drink wine.
Discussion
In this cross-sectional population-based study we ob-
served that both recent and lifetime alcohol intake from
wine showed a positive association with pulmonary func-
tion but total alcohol intake was not significantly associ-
ated with lung function. The association between lung
function and white wine was slightly stronger than that
for red wine but these two variables were highly correlated
and residual confounding by healthy lifestyle factors
might explain the difference.
We did not detect a significant association between lung
function and total alcohol intake. Some, but not all, pre-
vious studies have shown a negative association of alco-
hol intake with pulmonary function [18–25]. Taken all
studies together, total alcohol intake might not be strong-
ly associated with pulmonary function, but the underly-
ing reason for the conflicting evidence may, at least in
part, be related to the failure of studying beverage specific
alcohol in most of these studies. Our study supports this
latter hypothesis. The results suggest that among all con-
sidered alcoholic beverages, alcohol intake from wine,
both recent and lifetime intake, has the strongest relation
to FEV1 and FVC%. Alcohol from beer and liquor is not
significantly related to pulmonary function. Evidence sug-
gests that alcohol may increase oxidative burden [12–15].
However, while alcohol could potentially act as an oxi-
dant, there is a large body of evidence that wine has anti-
oxidant properties [12,13,16,17]. Our data indicate that
these antioxidant properties might exist and could have
positive influence on lung function. To our knowledge
only one other study has investigated the effects of bever-
age specific alcohol intake on pulmonary function. Cohen
et al. failed to find a protective effect of wine intake on
pulmonary function [18]. These authors 'classified partic-
ipants into categories of light, moderate and heavy drink-
ers based on the amount (drinks per occasion) and
frequency (rarely, occasionally, weekly and daily) of con-
sumption of alcoholic beverages. Thus, due to the use of a
categorical variable Cohen et al. had less power to detect
an association [18]. In addition, the authors analyzed pul-
monary function as the ratio of FEV1/FVC only and, con-
sequently, focused on an indicator of airway obstruction.
Therefore, the results are not directly comparable to those
of our study.
FEV1 and FVC are highly correlated in populations with-
out significant degree of airway obstruction. Thus, results
of the analysis between antioxidants and FEV1 or FVC will
be similar unless in a population free of reported lung dis-
ease very strong effects on airway narrowing or airflow
limitation are present. This study shows that both FEV1
and FVC are associated with wine intake and this leaves us
with little evidence for a strong effect of alcohol intake on
airway narrowing.
We found that both recent and lifetime alcohol intake
from wine was positively associated with lung function.
This finding is important because the correlation between
the recent and lifetime alcohol intake was not strong. It
could also indicate that the effects are not related to recent
intake of antioxidants from wine only but that long-term
intake may exert positive effects on lung function. In gen-
eral, we did not find independent additional effects of life-
time alcohol consumption after we included current
alcohol intake. Thus, the results indicate no independent
effect of lifetime alcohol intake beyond current intake.
Our analysis also suggests that wine intake may be associ-
ated with other healthy lifestyle characteristics (table 2).
Participants who drank only wine tended to be lighter,
more educated, smoke less and appeared to have a health-
ier diet. However, our findings persisted even after adjust-
ing for known covariates related to pulmonary function,
i.e. smoking, weight, micronutrients and socioeconomic
status. Nevertheless, although we adjusted for several life-
style variables in our regression analysis, the association
of wine intake with pulmonary function may be due to re-
sidual confounding by healthy lifestyle as reported previ-
ously [35–38].
If our findings are real, the observation that the associa-
tion with wine intake was slightly stronger for white wine
than for red wine is surprising, because it has been sug-
gested that red wine has greater health benefits than white
wine and this may be due to greater antioxidant capacity
[39]. Other research has indicated that both white and red
wine have beneficial health effects and similar antioxidant
properties [40]. The total antioxidant capacity of wine and
the relative antioxidant properties of white and red wine
vary depending on the assays used and no consensus has
been reached. There is strong evidence that the antioxi-
dant properties of wine are, at least in part, due to activity
of different flavonoids and other compounds [41]. In ad-
dition, white wine contains several phenols with antioxi-
dant activity [42,43].BMC Pulmonary Medicine 2002, 2 http://www.biomedcentral.com/1471-2466/2/3
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Alternatively, it is conceivable that the stronger associa-
tion of white wine with pulmonary function compared
with red wine may also be due to confounding by other,
healthy lifestyle factors. Approximately 74% of the partic-
ipants reported both red and white wine intake during
their lifetime. Compared with those who drank red wine
but not white wine, total pack years of smoke exposure
was higher in participants who reported white and red
wine intake together (15.7 versus 10.9 pack years, p <
0.05) and, thus, residual confounding by smoking and/or
other lifestyle factors could again explain our findings. Be-
cause of the limited sample size in the subgroups of wine
drinkers we were unable to provide strong data in groups
who only consumed either red or white wine.
Our results did not change significantly when we restrict-
ed the analysis to participants below the median of total
alcohol consumption. In this restricted sample mean alco-
hol intake from specific beverages differed little and alco-
hol intake from wine remained the strongest correlate of
lung function even after adjustment for other beverage
specific alcohol intake. This finding indicates that if those
with the heaviest alcohol intake were excluded, the pat-
tern of association between beverage specific alcohol in-
take and lung function was similar and could support a
true positive effect of wine on lung health.
Because cigarette smoke is a major source of oxidants we
would expect a stronger association of wine intake with
pulmonary function in smokers if wine has antioxidant
capacity that prevents smoking induced oxidative dam-
age. We failed to observe a statistically significant interac-
tion of beverage specific alcohol intake with smoking.
However, we should interpret this finding with caution,
because of the limited sample size of current smokers.
Our study has several limitations. First, the cross-sectional
design and, following from this design, the uncertainty
about the cause-effect relation represent a weakness of our
study. However, we obtained a lifetime drinking alcohol
history using an instrument with good test-retest reliabil-
ity [33], an approach that has not previously been used. A
second limitation is the limited power to perform more
definite subgroup analysis by smoking status or in groups
who consumed a single beverage type only. A third limi-
tation is the moderate participation rate and, as a conse-
quence, the restricted generalization of the results to the
general public.
The strength of this study is the detailed evaluation of in-
formation on covariates, including smoking and dietary
habits that have shown a relation to lung function. How-
ever, we cannot definitely exclude residual confounding
of health lifestyle factors, such as diet and smoking. Wine
drinkers and in particular white wine drinkers, may differ
from the rest of the population in other lifestyle factors
that we did not include in this analysis. Drinking patterns,
such as alcohol consumption with or without food could
also play a role. Since there is no information on the rela-
tion of white and red wine intake with lung function and
few studies have analyzed beverage specific alcohol intake
in relation to lung function, this study is important in that
it suggests the importance of beverage type in assessing
the relation of alcohol to pulmonary outcomes.
Conclusions
In conclusion, we found a positive association of recent
and lifetime wine intake with lung function. Contrary to
the expectations, (based on the findings from in vitro
studies showing that red wine has higher antioxidant po-
tentials) we found that white wine was the only wine type
significantly associated with lung function. Wine drinking
in general was associated with healthier characteristics
and better life style habits. Our findings appear independ-
ent of the potential confounding effect of numerous and
well measured factors (i.e. smoking, weight, socioeco-
nomic status, dietary antioxidant intake); however we
cannot exclude the potential of residual confounding.
Other unmeasured factors or errors in measurements in
the factors included in the analyses could be responsible
for the observed associations. In particular, we have to
note that among the different types of wine, consumption
of white wine was associated with healthier characteristics
and better life style profile than consumption of red wine.
In the absence of a biological plausibility for this differen-
tial effect of red and white wine on lung function we are
concerned about the potential spurious nature of the ob-
served associations. However, flavonoids and phenols are
antioxidants found in wine products that have been im-
plicated to play a role in lung health/function and may ex-
plain the observed associations. Further studies with
detailed information on potential confounders and in so-
cial and ethnic settings were the correlates of drinking
habits may differ from those reported here are needed to
confirm our results and help clarify whether there is a re-
lationship between the use of specific alcoholic beverages
and lung health.
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